Speaking of malaria

Over 99% of malaria cases in Brazil occur in the Amazonian region where access to quality treatment can be limited. Take a listen to hear the experiences of Dr Dhelio Pereira, Brazilian medical doctor and Research Director at the Centre of Parasitology and Tropical Medicine, and Dr Elodie Jambert, Director of Access and Product Management at MMV, on the challenges inherent in rolling out a new malaria treatment to patients in remote areas in the Amazon, and how these challenges can be addressed.

The medicines that prevent and treat malaria should be tailored to the geographies in which they are deployed and meet the unique needs of pregnant women and the youngest patients.

The medicines that prevent and treat malaria should be tailored to the geographies in which they are deployed and meet the unique needs of pregnant women and the youngest patients.

Over 99% of malaria cases in Brazil occur in the Amazonian region where access to quality treatment can be limited. Take a listen to hear the experiences of Dr Dhelio Pereira, Brazilian medical doctor and Research Director at the Centre of Parasitology and Tropical Medicine, and Dr Elodie Jambert, Director of Access and Product Management at MMV, on the challenges inherent in rolling out a new malaria treatment to patients in remote areas in the Amazon, and how these challenges can be addressed.

At the start of the COVID-19 pandemic, modeling analyses predicted that the spread of this new disease would lead to an increase in malaria deaths. COVID-19 would burden health systems, prevent proper access to medicines and disturb prevention campaigns. More than a year later, where do we stand? Pedro Alonso, the director of the World Health Organization’s Global Malaria Programme, reflects on this crisis and shares his hopes for the future of science and health.

The COVID-19 pandemic has disturbed many aspects of our lives. Entire societies and their health systems have struggled to adapt to this new challenge. Medicine for Malaria Venture works to prevent and cure malaria in endemic countries. This past year the organization has had to address the threat of two deadly diseases: malaria and COVID-19. The CEO, David Reddy takes us behind the scenes to share his lessons learnt and the challenges that still lie ahead.

Malaria is a disease whose main victims are children. In The Gambia, the four months of the rainy season are also the peak period for malaria. Children need to take preventive medicine to be protected against the malaria parasite during this time. Olimatou is a health worker who organizes these prevention campaigns - with an added difficulty since 2020: the Covid-19 pandemic.

The COVID-19 pandemic has disturbed many aspects of our lives. Entire societies and their health systems have struggled to adapt to this new challenge. Medicine for Malaria Venture works to prevent and cure malaria in endemic countries. This past year the organization has had to address the threat of two deadly diseases: malaria and COVID-19. The CEO, David Reddy takes us behind the scenes to share his lessons learnt and the challenges that still lie ahead.

Malaria is a disease whose main victims are children. In The Gambia, the four months of the rainy season are also the peak period for malaria. Children need to take preventive medicine to be protected against the malaria parasite during this time. Olimatou is a health worker who organizes these prevention campaigns - with an added difficulty since 2020: the Covid-19 pandemic.

At the start of the COVID-19 pandemic, modeling analyses predicted that the spread of this new disease would lead to an increase in malaria deaths. COVID-19 would burden health systems, prevent proper access to medicines and disturb prevention campaigns. More than a year later, where do we stand? Pedro Alonso, the director of the World Health Organization’s Global Malaria Programme, reflects on this crisis and shares his hopes for the future of science and health.